In early January of 2024, Qvin made history; the FDA clearance of its Q-Pad and A1c Test marked the first FDA approval for menstrual blood health testing.
March 2, 2026
Portfolio
The next-generation code forge built for the future
February 9, 2026
The Sovereign AI Layer for Europe’s Public Sector
February 6, 2026
Making power truly invisible.